Our results showed significantly inhibited pancreatic tumor cell growth by TLR2 and TLR9 intrabodies, significantly decreased inflammatory cytokines IL-6 and TNF-α, and increased apoptotic mediators Caspase 8 and cleaved Caspase 3. The gene discussed is TLR9; the disease is pancreatic neoplasm.